Much of the noise surrounding transcatheter aortic valve replacement (TAVR) vs. its surgical counterpart has to do with residual paravalvular leak. However, a new paper in the Journal of the American College of Cardiology (JACC) seems to have overwritten that consideration. The underlying registry study indicates that procedural success and outcomes at one year are superior in TAVR to in SAVR – yet another piece of evidence that seemingly tips the scales even more toward TAVR devices.
NEW DELHI – India, which has the highest incidence of tuberculosis (TB) in the world and the second highest of COVID-19, is looking to artificial intelligence (AI) to help detect and classify cases of both and lower the cost of diagnosis.
Keeping you up to date on recent developments in neurology, including: Focused ultrasound shows promise for Parkinson’s disease; Blood test developed for Alzheimer’s prognosis in symptom-free patients; Bedside EEG test predicts recovery in unresponsive brain injury patients.
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA formally posts testing advisory after town hall discussion; HHS finalizes regulatory review rule; Lab in California hit for three months of false claims; BVMed calls for German med tech strategy.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inari Medical.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4basecare, Applied Biosystems, Applied DNA Sciences, Blue Note Therapeutics, Caredx, Crown Bioscience, Emulate, Labcorp, Myriad Genetics, Pacific Biosciences, Transchart.
RSS
